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Abstract
Introduction: Transfusion in trauma is often empiric or based on traditional lab tests. Viscoelastic tests such as
thromboelastography (TEG®) and rotational thromboelastometry (ROTEM®) have been proposed as superior to
traditional lab tests. Due to the similarities between the two tests, general opinion seems to consider them
equivalent with interchangeable interpretations. However, it is not clear whether the results can be similarly
interpreted. This review evaluates the comparability between TEG and ROTEM and performs a descriptive review of
the parameters utilized in each test in adult trauma patients.
Methods: PUBMED database was reviewed using the keywords “thromboelastography” and “compare”, between
2000 and 2011. Original studies directly comparing TEG® with ROTEM® in any area were retrieved. To verify the
individual test parameter used in studies involving trauma patients, we further performed a review using the
keywords “thromboelastography” and “trauma” in the PUBMED database.
Results: Only 4 studies directly compared TEG® with ROTEM®. One in liver transplantation found that transfusion
practice could differ depending on the device in use. Another in cardiac surgery concluded that all measurements
are not completely interchangeable. The third article using commercially available plasma detected clinically
significant differences in the results from the two devices. The fourth one was a head-to-head comparison of the
technical aspects. The 24 articles reporting the use of viscoelastic tests in trauma patients, presented considerable
heterogeneity.
Conclusion: Both tests are potentially useful as means to rapidly diagnose coagulopathy, guide transfusion and
determine outcome in trauma patients. Differences in the activators utilized in each device limit the direct
comparability. Standardization and robust clinical trials comparing the two technologies are needed before these
tests can be widely recommended for clinical use in trauma.
Introduction
Coagulation is a complex, dynamic, highly regulated and
interwoven process involving a myriad of cells, mole-
cules and structures. Only recently, the unique changes
in coagulation caused by trauma are starting to be
understood, but remain mostly unknown [1,2]. Trauma
patients are among the largest consumers of blood and
blood products and the decision of what, when and how
much blood and blood product to transfuse is often
empiric or based on traditional coagulation lab tests
such as INR/PT, PTT and platelet count. However, tra-
ditional lab tests have been heavily criticized for their
limitations in assisting the physicians with the clinical
decision to transfuse, and alternatives are warranted.
The traditional laboratorial evaluation of coagulation
evolved initially to quantify specific cellular, molecular
or factor deficiencies. Numeric values (quantity) of indi-
vidual elements do not necessarily indicate how well
hemostasis is functioning. As an example, a cirrhotic
patient with low platelet count and an abnormal INR of
2 does not necessarily bleed and probably can tolerate
minor invasive procedures. In contrast, a hypothermic
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trauma patient with normal platelet count and INR
might bleed to death [3,4]. Another limitation of tradi-
tional lab tests is the prolonged time to obtain the
results or turnaround time. Dealing with rapid changes
as frequently occurs in massively bleeding trauma
patients, is challenging. In such situations, any delay in
obtaining the lab results can lead to inadequate transfu-
sion and increased morbidity and mortality [4]. Thus in
trauma, global, functional and immediately available
laboratorial evaluation of hemostasis can improve both
patient management and outcome.
Viscoelastic tests such as thromboelastography (TEG®)
and rotational thromboelastometry (ROTEM®) have
been enthusiastically proposed by some, as superior
compared to traditional lab tests. Both tests can be per-
formed as point of care, and the faster availability of
results may assist clinical decisions of what, when and
how much blood and products to transfuse [5-7]. Other
advantages of viscoelastic tests include their ability to
provide a global and functional assessment of coagula-
tion, which may prove superior to quantitative tests that
evaluate segments of the hemostasis. A recent systema-
tic review on massive transfusions concluded that
despite an apparent association with bleeding reduction,
the use of TEG® or ROTEM® to guide blood transfu-
sion remains uncertain [8].
The interest in TEG® and ROTEM® in trauma is
recent and the topic lacks large numbers of studies.
However, the available evidence suggests that TEG® and
ROTEM® could have important roles in trauma in 3
ways: by promptly diagnosing early trauma coagulopathy
(diagnostic tools); guiding blood transfusion and reveal-
ing patients’ prognosis. The two tests have the same
foundational principles and share many similarities,
from hardware (equipment) and procedures (technique)
to tracing (graph) and parameters. Figure 1 merges the
tracings obtained from both tests and Table 1 shows the
parameters from each test and their normal values.
The preference for which viscoelastic tests to use
appears to reside primarily on geography, with centers
in North America favouring TEG® while Europeans pre-
fer ROTEM®. Overall, the prevalent opinion is that the
two tests are equivalent with interchangeable results and
interpretations. It is curious to note however, that treat-
ment recommendations seem to vary according to
which test it is based on. Transfusion algorithms based
on ROTEM® appear to frequently recommend fibrino-
gen [9] while TEG®-based algorithms appear to recom-
mend plasma [7]. It is not clear whether the results
from these two apparently related tests are interchange-
able and can be similarly interpreted. Considering the
growing importance of TEG® and ROTEM® in trauma,
attested by the growing number of viscoelastic test
based algorithms and trauma centers adopting them as
standard of care, we proposed a literature review on the
topic. The goal is to appraise the evidence on the com-
parability between TEG® and ROTEM® as well as to
perform a descriptive review of the parameters used in
each test, in the setting of adult trauma patients.
Figure 1 TEG® and ROTEM® tracing TEG® parameters: R – reaction
time; k – kinetics; ∝ - alpha angle; MA – maximum amplitude; CL –
clot lysis. ROTEM® parameters: CT – clotting time; CFT – clot formation
time; ∝ - alpha angle; MCF – maximum clot firmness; LY – clot lysis.
Table 1 TEG® and ROTEM® parameters and their
reference values (adapted from Luddington 2005, and
Ganter MT, Hofer CK 2008).
TEG® ROTEM®















CFT (clot formation time)
Cit, EXTEM: 46-148s
Cit, INTEM: 40-100s










Amplitude (at a fixed
time)
A (A30, A60) A (A10, A15, A20, A25,
A30)








Cit, FIBTEM: 9 -25mm
Lysis (at a fixed time) CL30, CL60 CLY30, CLY60: 94 – 100%
Maximum lysis ML : <15%
TEG® parameters: R – reaction time; k – kinetics; ∝ - alpha angle; MA –
maximum amplitude; CL – clot lysis.
ROTEM® parameters: CT – clotting time; CFT – clot formation time; ∝ - alpha
angle;
MCF – maximum clot firmness; LY – clot lysis.
WB – whole blood; Cit – citrated blood.
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Methods
We performed a review of the literature searching
PUBMED database using the keywords “thromboelasto-
graphy” and “comparison”, between 2000 and 2011.
Studies were eligible for inclusion if they were original
and directly compared TEG® with ROTEM®. In view of
the possibility that only a small number of such studies
would be found, we decided to perform an additional
analysis. All studies on either TEG® or ROTEM® in
trauma were included and each individual test para-
meter was scrutinized on its role in diagnosing early
coagulopathy, guiding transfusion and indicating prog-
nosis. Then the role of similar test parameters from
TEG® and ROTEM® was compared aiming to identify
whether they were comparable. For this additional ana-
lysis the review used the keywords “thromboelastogra-
phy” and “trauma” in the PUBMED database. Studies
were excluded if they were experimental or consisted of
case reports. All full-text versions of the studies were
retrieved and duplicate studies were excluded.
In this review (see Table 1), the viscoelastic test para-
meters will be referred to as r/CT, when referring to the
initiation of the clotting process of both tests or as r when
specifically referring to TEG® or CT when specifically
referring to ROTEM®. Similarly, k/CFT will refer to ampli-
fication of the clotting process, MA/MCF to the maximal
clot firmness and CL/LI to fibrinolysis, in TEG® and
ROTEM® respectively. Alpha is similar in both tests (∝).
Results
Direct comparison of TEG® and ROTEM®
The literature search identified 191 studies, of which
only 4 directly compared TEG® with ROTEM® and
none were done in trauma. The two clinical studies
were in liver transplantation and in cardiac surgery,
another was an experiment using commercially available
plasma and the last was a head-to-head comparison of
the technical aspects, ease of use and costs [7,10-12].
Thus no study directly comparing TEG® with ROTEM®
in trauma was identified. Due to the paucity of compari-
sons, we considered them individually.
The first clinical study by Coakley et al. compared
transfusion triggers using TEG®, ROTEM® (INTEM®
and FIBTEM®) and traditional coagulation tests (PT,
platelet count and Clauss fibrinogen) during liver trans-
plantation [7]. This prospective observational study
showed a good correlation between TEG® MA and
ROTEM® MCF and they shared moderate agreement in
guiding platelet or fibrinogen transfusion. The study
concluded that transfusion could differ depending on
which device is used.
The second clinical study by Venema et al. compared
r/CT, k/CFT, MA/MCF and the ∝ angle during cardiac
surgery [10]. This study suggested that TEG® MA and
ROTEM® ∝ angle could be used interchangeably but the
other parameters are not fully interchangeable.
The third study by Nielsen compared the reaction
time, ∝ angle, maximal amplitude and maximal elastic
modulus between the two devices using native plasma,
celite-activated normal plasma as well as celite-activated
hypo and hypercoagulable plasma [11]. All TEG®
ROTEM® parameters were significantly different in
native plasma, while in celite-activated samples most
were comparable. The study concluded that the signifi-
cant differences in measurements from the two devices
could be attenuated with celite activation.
The head-to-head comparison of the two devices by
Jackson et al., took into consideration operational
aspects including installation requirements, warm-up
time, pipettes, material required, reference ranges, costs
and opinion of the lab staff [12]. This study consisted of
a simple subjective assessment of the advantages and
disadvantages of both devices.
Additional analysis of individual parameters from TEG®
and ROTEM® in trauma
The additional PUBMED search identified 24 manuscripts,
of which TEG® was tested in 10, rapid-TEG in 6 and
ROTEM® in 9. Two studies compared TEG® with rapid-
TEG®. No randomized controlled trial was found, 16
manuscripts analyzed data prospectively collected, 6 were
retrospective and 2 were “before and after” studies. The
techniques used to perform TEG® and ROTEM® in these
24 studies were noticeably heterogeneous. Different activa-
tors were used and different parameters evaluated making
general comparisons difficult. Table 2 summarizes the
main findings of the 24 manuscripts reviewed according to
the test parameters evaluated and whether TEG® or
ROTEM® were used to diagnose early coagulopathy, guide
transfusion or indicate prognosis.
Results of 12 studies on the use of TEG® or ROTEM® as
diagnostics tools
Among the studies on TEG® Schreiber et al reported a
correlation between r and PTT, and between MA and
platelet count [13]. While Plotkin et al found a similar
correlation between MA and platelet [14], Jeger et al
found that k, ∝ angle and MA correlated with platelet
levels and INR [15]. Park et al found no correlation
between either ∝ angle or MA to PT and PTT [16]
while Cotton et al (using Rapid TEG) reported a corre-
lation between ∝ angle and MA with platelet, PT and
PTT. In this study G was failed to correlate with any
traditional lab tests [17].
Johansson et al reported that all the TEG® parameters
improved after the administration of predefined transfu-
sion packages [18]. Watters et al reported that MA
parameters were higher in patients after splenectomy
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Table 2 The results and correlation of TEG® and ROTEM® parameters in each study for diagnosis, transfusion guidance
and prognosis
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[19]. Using the platelet mapping sequence in the TEG®,
Nekludov found that bleeding patients have reduced pla-
telet response to arachdonic acid [20].
In ROTEM® studies Rugeri found that CA15-EXTEM®
correlated with PT, CA15-INTEM® with platelets and
PTT, and CA10-FIBTEM® with fibrinogen [21]. Levrat
et al noted that in EXTEM® CA10, MCF and CLI60 cor-
related well with the euglobulin lysis time, which they
used as the gold standard to detect fibrinolysis [22].
Davenport et al reported that CA5 could be an early indi-
cator of coagulopathy in trauma and CT, CA and MCF
improved after transfusion [23,24].
In summary, the single apparent similarity between
TEG® and ROTEM® parameters when used to diagnose
coagulopathy in trauma is between TEG® MA and
ROTEM® MCF and their similar association to platelet
count and PTT.
Results of the 2 studies on the use of TEG® and ROTEM®
in guiding transfusion in trauma
In a retrospective study, Kashuk et al suggested that
using TEG® parameters such as r to guide transfusion
may lead to a reduction in plasma transfusion [25].
Schochl et al reported that ROTEM®-based protocols
are useful to guide transfusion of fibrinogen concen-
trates and prothrombin complex that in turn reduce the
need for transfusion of red blood cells and platelets [26].
As summarized in Table 2, no similarity between TEG®
and ROTEM® can be made from these studies.
Results of the 11 studies on the use of TEG® and ROTEM®
and outcome in trauma
Plotkin et al in a retrospective study on TEG® reported
that low MA correlated with increased transfusion
requirement [14]. For ROTEM®, 2 studies by Leeman
et al and Doran et al reported the same finding with
MCF (INTEM®), the later study also showed that
reduced MCF (EXTEM®) is useful to guide transfusion
[27,28].
Park developed a prognostic scoring system for
trauma patients using inflammatory and coagulation
parameters, in which of all TEG® parameters only MA
was an independent predictor of mortality [29]. Carroll
also detected a significant correlation between TEG®
platelet mapping and transfusion requirements, and a
correlation between r and MA values with mortality
[30]. Kashuk in both a “before and after” and a prospec-
tive observational study found that TEG® G values were
associated with survival [31]. Similarly Pezold in a retro-
spective TEG® study found that low G values were asso-
ciated with both increased transfusion requirements and
mortality [32]. Both, Johansson (“before and after”
TEG® study) and Schochl (ROTEM® retrospective
study) suggested that viscoelastic tests guided transfu-
sion reduced mortality [5,9]. Schochl also reported that
hyperfibrinolysis, detected by ROTEM® ML correlated
with higher mortality and this parameter could be used
to classify the degree of severity of the fibrinolysis [33].
In 2010 Kashuk et al found that abnormal primary lysis
detected by elevated CL (similar to ROTEM® ML) is
also associated with mortality [31].
As summarized on Table 2, these 11 studies showed
that some TEG® and ROTEM® parameters are similarly
associated with outcomes in trauma. TEG® MA and
ROTEM® MCF are associated with both the need for
blood transfusion and mortality, while excessive fibrino-
lysis diagnosed by either TEG® CL or ROTEM® ML are
independent predictors of mortality.
Table 2 The results and correlation of TEG®?®? and ROTEM®?®? parameters in each study for diagnosis, transfusion



























Abbreviations: r, k, a and MA – TEG® parameters; CT,CFT, a, MCF, CA10, CA15, CL30-CL60 – ROTEM
® parameters; ACT – activated clotting time; ELT – euglobulin
lysis time; FFP – fresh frozen plasma; G – maximal elastic modulus (d/sc); PC – platelet concentrate; PCC – prothrombin complex concentrate; Tx – transfusion
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Discussion
A few deductions can be promptly reached from review-
ing the literature on these two viscoelastic tests. First
that there is a lot of enthusiasm supporting their clinical
application in trauma. The literature suggests that both
tests are already being used in many institutions, which
could be in a wider scale than suggested by the limited
number of publications. The wide clinical application of
any technology without supporting evidence and scienti-
fic validation is worrisome and more investigations on
these tests are urgently needed and warranted.
Another plausible conclusion from this review is that
the prevalent notion that the two tests are equivalent
with interchangeable results and interpretations may be
unfounded. While there are insufficient studies to sup-
port any conclusions on the topic, the current evidence
indicates only a small number of similarities between the
tests. Concerning their diagnostic capacity, the similari-
ties found were limited to TEG® MA and ROTEM®
MCF and their similar association with platelet count
and PTT. Another apparent similarity was of TEG® CL
and ROTEM® ML in diagnosing excessive fibrinolysis
and mortality (prognosis). Prognostication was where
these tests showed more similarities. TEG® MA and
ROTEM MCF® were also linked to the need for blood
transfusion and mortality. The few studies on TEG®- or
ROTEM®-based transfusion algorithms suggested that
while both tests can be used to construct transfusion
guidelines, the blood products transfused differ according
to the algorithm selected.
Even tough no study could be found directly comparing
TEG® and ROTEM® in trauma; two studies have com-
pared the 2 tests in transplant and cardiac surgery. Coak-
ley et al., in the liver transplant study concluded that
transfusion practice could differ depending on the visco-
elastic coagulation-monitoring device in use. Venema
et al., verified that kaolin-activated TEG® measurements
correlated with those of EXTEM®, but not all the mea-
surements of the two devices are interchangeable. These
findings seem to support the concept that despite simila-
rities, interchangeable interpretation is not recommended
without further studies and standardizations.
Despite being used for a number of years, the recent
wider adoption and transfer of the technology to the
hemostasis laboratory has raised some concerns regarding
these techniques. Among the concerns pointed out in the
literature are the effect of age [34-37], gender [38], use of
citrated blood sample [39], sampling site, stability and
repeated sampling [40-43] on the results observed. A
number of activators and inhibitors are commonly used
resulting in varied specificity of the assay [44]. Different
methods of data analysis have also been suggested [45]. In
an interesting article Jackson et al “road tested” both
TEG® and ROTEM® and summarized their finding
regarding technical features, costs and pooled the opinion
of the direct users [12]. The reproducibility of both TEG®
and ROTEM® measurements has been reported as accep-
table [46].
A recent systematic review of randomized clinical trials
comparing TEG®- or ROTEM®-based algorithms with
standard treatment in non-trauma bleeding patients found
that the current evidence supporting viscoelastic tests is
weak [4]. This systematic review found only 9 randomized
controlled trials, 8 in cardiac surgery and 1 in liver trans-
plantation. Possibly the greatest contribution of the viscoe-
lastic tests is in the detection of hyperfibrinolysis, which
no other test can diagnose as expeditiously.
Interestingly, Nielsen pointed out in his study that
TEG® and ROTEM® could potentially generate similar
data, provided similar activators were utilized in both
devices. This observation highlights the need for stan-
dardization if the tests are to be comparable. Meanwhile,
caution must be exercised in utilizing treatment algo-
rithms based on one system while analyzing patient
samples from the other, or even the same system but
using different activators.
In conclusion, TEG® and ROTEM® have many of the
characteristics of ideal tests for use in trauma including
global evaluation of coagulation, both quantitative and
functional assessment, in vitro assays performed under
conditions of ”no flow”. Their potential clinical utility
must be balanced against limitations particularly the
considerable heterogeneity in methods, reagents and
parameters evaluated. The present literature review sug-
gests that in trauma TEG® and ROTEM® are not fully
equivalent tests with interchangeable results and inter-
pretations but as pointed out by Nielsen, this could be
the results of using different activators (methods). The
similarities identified were limited to TEG® MA and
ROTEM® MCF measurements and their association
with platelet counts and PTT. Other similarities were
between TEG® CL and ROTEM® ML in diagnosing
excessive fibrinolysis and mortality and TEG® MA and
ROTEM® MCF association with blood transfusion and
mortality.
Despite their limitations, both tests are attractive and
potentially useful as means to rapidly diagnose coagulo-
pathy, guide transfusion and determine outcome of
adult trauma patients. However, standardization and
robust clinical trials comparing the two technologies are
needed before these promising tests can be widely
recommended for clinical use in trauma.
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